{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:48:53Z","timestamp":1774122533041,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.vaccine.2006.04.037","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T11:13:20Z","timestamp":1147173200000},"page":"5726-5733","source":"Crossref","is-referenced-by-count":20,"title":["Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: Comparison with Glaxo-Evans 1077 BCG vaccine"],"prefix":"10.1016","volume":"24","author":[{"given":"Patricia","family":"Gorak-Stolinska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary E.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve K.","family":"Lalor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Stenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Branson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Blitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Luke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ben-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.M.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2006.04.037_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/thx.45.2.83","article-title":"BCG vaccination of schoolchildren in England and Wales","volume":"45","author":"Springett","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2006.04.037_bib2","unstructured":"Department of Health. Important information for medical and healthcare professionals about new BCG vaccine Statens Serum Institut. vol. 2002, Department of Health; 2002. (Professional letter PL CO (2002)1 and appendices 1, 2 and 3). http:\/\/www.dh.gov.uk\/PublicationsAndStatistics\/LettersAndCirculars\/ProffessionalLetters\/ChiefOfficerLetters\/ChiefofficerLettersArticles\/fs\/en?CONTENT_ID=4004834&chk=YvEAjX."},{"issue":"6082","key":"10.1016\/j.vaccine.2006.04.037_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"2","author":"Hart","year":"1977","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.037_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0041-3879(87)90023-7","article-title":"Effectiveness of BCG vaccination in England and Wales in 1983","volume":"68","author":"Sutherland","year":"1987","journal-title":"Tubercle"},{"issue":"728","key":"10.1016\/j.vaccine.2006.04.037_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.4.5728.148","article-title":"Comparison of the efficacy of liquid and freeze-dried strains of B.C.G. vaccine in preventing tuberculosis","volume":"4","author":"Springett","year":"1970","journal-title":"Br Med J"},{"issue":"20","key":"10.1016\/j.vaccine.2006.04.037_bib6","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.vaccine.2004.07.052","article-title":"BCG vaccine-associated suppurative lymphadenitis","volume":"23","author":"Teo","year":"2005","journal-title":"Vaccine"},{"issue":"9315","key":"10.1016\/j.vaccine.2006.04.037_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.037_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2249.2003.02272","article-title":"Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria","volume":"134","author":"Weir","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2006.04.037_bib9","unstructured":"Department of Health. Tuberculosis: BCG immunisation. In: Salisbury DM, Begg NT, editors. Immunisation against infectious disease. 2nd ed. London: HMSO; 1996, p. 219\u201341."},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.037_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0962-8479(96)90025-8","article-title":"Does bacille Calmette-Guerin scar size have implications for protection against tuberculosis or leprosy?","volume":"77","author":"Sterne","year":"1996","journal-title":"Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2006.04.037_bib11","first-page":"664","article-title":"Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi","volume":"5","author":"Black","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.037_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/322042","article-title":"Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi","volume":"184","author":"Black","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.037_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0092-1157(77)90012-9","article-title":"Evaluation of BCG vaccines in children, the effect of strain and dose","volume":"5","author":"Bunch-Christensen","year":"1977","journal-title":"J Biol Stand"},{"issue":"5","key":"10.1016\/j.vaccine.2006.04.037_bib14","first-page":"489","article-title":"Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains","volume":"51","author":"Vallishayee","year":"1974","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.037_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-1157(83)80040-7","article-title":"A comparative study of Danish (Statens Seruminstitut), Glaxo and Behringwerke vaccines\u2013revaccination of schoolchildren","volume":"11","author":"Bottiger","year":"1983","journal-title":"J Biol Stand"},{"issue":"2","key":"10.1016\/j.vaccine.2006.04.037_bib16","first-page":"47","article-title":"Second IUATLD study on complications induced by intradermal BCG-vaccination","volume":"63","author":"Lotte","year":"1988","journal-title":"Bull Int Union Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.037_bib17","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.037_bib18","first-page":"125","article-title":"Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains","volume":"134C","author":"Gheorghiu","year":"1983","journal-title":"Ann Immunol (Paris)"},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.037_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000441-199706000-00009","article-title":"In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines","volume":"313","author":"Lein","year":"1997","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2006.04.037_bib20","first-page":"441","article-title":"Whole blood cytokine assays\u2014a new generation of diagnostic tests for tuberculosis?","volume":"2","author":"Dockrell","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2006.04.037_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/CDLI.7.2.155-160.2000","article-title":"Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10","volume":"7","author":"van Pinxteren","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9364","key":"10.1016\/j.vaccine.2006.04.037_bib22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","article-title":"Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak","volume":"361","author":"Ewer","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2006.04.037_bib23","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2006.04.037_bib24","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2006.04.037_bib25","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Olsen","year":"2001","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.04.037_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2006.04.037_bib27","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1086\/313874","article-title":"Correlates of protective immunity to Mycobacterium tuberculosis in humans","volume":"30","author":"Ellner","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2006.04.037_bib28","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/S0264-410X(00)00519-3","article-title":"Tuberculosis subunit vaccine development: on the role of interferon-gamma","volume":"19","author":"Agger","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2006.04.037_bib29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/344359","article-title":"Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity","volume":"186","author":"Hoft","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.04.037_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","article-title":"Preclinical testing of new vaccines for tuberculosis: a comprehensive review","volume":"24","author":"Orme","year":"2006","journal-title":"Vaccine"},{"issue":"5419","key":"10.1016\/j.vaccine.2006.04.037_bib31","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2006.04.037_bib32","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/S0264-410X(00)00369-8","article-title":"Identification of substrains of BCG vaccine using multiplex PCR","volume":"19","author":"Bedwell","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2006.04.037_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/003655401300077180","article-title":"Correlation between BCG genomics and protective efficacy","volume":"33","author":"Behr","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.04.037_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0962-8479(92)90149-E","article-title":"The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989","volume":"73","author":"Romanus","year":"1992","journal-title":"Tuberc Lung Dis"},{"issue":"8986","key":"10.1016\/j.vaccine.2006.04.037_bib35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.04.037_bib36","unstructured":"Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1980;72(Suppl.):1\u201374."},{"key":"10.1016\/j.vaccine.2006.04.037_bib37","unstructured":"Tuberculosis Research Centre, Chennai. Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1999;110:56\u201369."},{"key":"10.1016\/j.vaccine.2006.04.037_bib38","unstructured":"Tuberculosis Research Centre, Chennai. Influence of sex, age and non tuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in south India. Indian J Med Res 2006;123(2):119\u201324."},{"key":"10.1016\/j.vaccine.2006.04.037_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0041-3879(67)80024-2","article-title":"The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in tuberculin sensitivity and to technical variations in vaccines","volume":"48","author":"Hart","year":"1967","journal-title":"Tubercle"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06004890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T16:17:30Z","timestamp":1586881050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06004890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":39,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0264410X06004890"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}